Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Reviews

Targeted therapeutic approaches for hormone-refractory prostate cancer. Cancer Treat Rev. 2010 Apr;36(2):122–30.
The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol. 2010 Jan 1;79(1):1–9.
Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci. 2009 Dec 15;287(1–2):1–6.
Vitamin D, cardiovascular disease and mortality in patients with kidney disease. Ugeskr Laeger. 2009 Dec 7;171(50):3684–9.
Gene polymorphisms and prostate cancer: the evidence. BJU Int. 2009 Dec;104(11):1560–72.
Gender differences in multiple sclerosis: Cytokines and vitamin D. Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S265–77.
A new role for vitamin D receptor activation in chronic kidney disease. Am J Physiol Renal Physiol. 2009 Dec;297(6):F1502–9.
Vitamin D: an evidence-based review. J Am Board Fam Med. 2009 Nov–Dec;22(6):698–706.
Vitamin D treatment in multiple sclerosis. J Neurol Sci. 2009 Nov 15;286(1–2):104–8.
Weighty concerns: the growing prevalence of obesity among older adults. J Am Diet Assoc. 2009 Nov;109(11):1886–95.
Vitamin D supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007298.
Impact of micronutrient deficiencies on obesity. Nutr Rev. 2009 Oct;67(10):559–72.
Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin North Am. 2009 Oct;56(5):1105–21.
Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol. 2009 Oct;16(10):1083–9.
Vitamin D and respiratory health. Clin Exp Immunol. 2009 Oct;158(1):20–5.
Ultraviolet radiation and Vitamin D3 in amphibian health, behaviour, diet and conservation. Comp Biochem Physiol A Mol Integr Physiol. 2009 Oct;154(2):184–90.
Calcitriol (Vectical) for mild to moderate plaque psoriasis. Med Lett Drugs Ther. 2009 Sep 7;51(1320):70–1.
Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009 Sep;4(9):1515–22.
Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 2009 Sep;29(9):3699–704.
Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention. Anticancer Res. 2009 Sep;29(9):3705–12.
Calcium, vitamin D and cancer. Anticancer Res. 2009 Sep;29(9):3687–98.
Solar radiation, vitamin D and cancer incidence and mortality in Norway. Anticancer Res. 2009 Sep;29(9):3501–9.
How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res. 2009 Sep;29(9):3675–84.
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. Anticancer Res. 2009 Sep;29(9):3597–604.
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009 Sep;29(9):3511–36.
Women's mental health: depression and anxiety. Nurs Clin North Am. 2009 Sep;44(3):355–64.
Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia. 2009 Sep;50 Suppl 8:42–50.
Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009 Sep;122(9):793–802.
Vitamin D and adolescents: what do we know? Curr Opin Pediatr. 2009 Aug;21(4):465–71.
Severe osteomalacia presenting with multiple vertebral fractures: a case report and review of the literature. Endocrine. 2009 Aug;36(1):30–6.
Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy. J Drugs Dermatol. 2009 Aug;8(8 Suppl):s17–22.
Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis. J Drugs Dermatol. 2009 Aug;8(8 Suppl):s9–16.
The role of topical vitamin D modulators in psoriasis therapy. J Drugs Dermatol. 2009 Aug;8(8 Suppl):s4–8.
Bile acids as regulatory molecules. J Lipid Res. 2009 Aug;50(8):1509–20.
Hyperparathyroidism. Lancet. 2009 Jul 11;374(9684):145–58.
The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review. South Med J. 2009 Jul;102(7):765–8.
Osteoporosis in inflammatory bowel disease. Am J Med. 2009 Jul;122(7):599–604.
Osteoporosis in Parkinson's disease. Parkinsonism Relat Disord. 2009 Jun;15(5):339–46.
Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection. Inflamm Allergy Drug Targets. 2009 Jun;8(2):161–8.
Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr. 2009 Jun;89(6):1997S–2008S.
Glucocorticoid resistance in inflammatory diseases. Lancet. 2009 May 30;373(9678):1905–17.
Vitamin D requirements in the first year of life. Curr Opin Clin Nutr Metab Care. 2009 May;12(3):287–92.
Differentiation therapy of leukemia: 3 decades of development. Blood. 2009 Apr 16;113(16):3655–65.
Interventions for preventing falls in elderly people. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000340.
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009 Apr 15;179(8):630–6.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000227.
Genetics of bone loss in rheumatoid arthritis—role of vitamin D receptor polymorphisms. Rheumatology (Oxford). 2009 Apr;48(4):342–6.
Final Declaration of the Asian Metaforum on the Role of Vitamin D and the Management of Osteoporosis. Public Health Nutr. 2009 Apr;12(4):578–80.
Bile Acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol Sci. 2009 Apr;108(2):225–46.
Management of osteoporosis among home health and long-term care patients with a prior fracture. South Med J. 2009 Apr;102(4):397–404.
Vitamin D and skin cancer: A meta-analysis. Eur J Cancer. 2009 Mar;45(4):634–41.
Nutrition and heart failure: impact of drug therapies and management strategies. Nutr Clin Pract. 2009 Feb–Mar;24(1):60–75.
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res. 2009 Feb 15;81(3):500–8.
Endocrine function in naturally long-living small mammals. Mol Cell Endocrinol. 2009 Feb 5;299(1):101–11.
Diagnosis and treatment of osteoporosis. Am Fam Physician. 2009 Feb 1;79(3):193–200.
The effects of obesity surgery on bone metabolism: what orthopedic surgeons need to know. Am J Orthop. 2009 Feb;38(2):77–9.
A brief history of vitamin d and cancer prevention. Ann Epidemiol. 2009 Feb;19(2):79–83.
Vitamin D and pancreatic cancer. Ann Epidemiol. 2009 Feb;19(2):89–95.
Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009 Feb;19(2):84–8.
Can the Mediterranean diet prevent prostate cancer? Mol Nutr Food Res. 2009 Feb;53(2):227–39.
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008. J Allergy Clin Immunol. 2009 Feb;123(2):319–27.
Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post–)transcriptional modulators? Clin Rev Allergy Immunol. 2009 Feb;36(1):52–61.
Uranium: properties and biological effects after internal contamination. Ann Biol Clin (Paris). 2009 Jan–Feb;67(1):23–38.
Improvement of chronic back pain or failed back surgery with vitamin D repletion: a case series. J Am Board Fam Med. 2009 Jan–Feb;22(1):69–74.
Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res. 2009 Jan;301(1):57–64.
Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol. 2009 Jan;156(1):7–27.
Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets. 2009 Jan;13(1):29–38.
Klotho gene, phosphocalcic metabolism, and survival in dialysis. J Ren Nutr. 2009 Jan;19(1):50–6.
Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009 Jan;94(1):26–34.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61.
Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2009 Jan;38(1):43–54.
Review article: vitamin D acquisition and breast cancer risk. Reprod Sci. 2009 Jan;16(1):7–19.
Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther. 2009;11(2):218.
Prevention of ER-negative breast cancer. Recent Results Cancer Res. 2009;181:121–34.
Induction of tolerogenic dendritic cells by vitamin d receptor agonists. Handb Exp Pharmacol. 2009;(188):251–73.
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity. Mol Aspects Med. 2008 Dec;29(6):433–52.
Vitamin D supplementation during lactation to support infant and mother. J Am Coll Nutr. 2008 Dec;27(6):690–701.
Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol Aspects Med. 2008 Dec;29(6):415–22.
Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements. Fam Pract. 2008 Dec;25 Suppl 1:i44–9.
Prenatal factors and the development of asthma. Curr Opin Pediatr. 2008 Dec;20(6):682–7.
The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8.
Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):489–94.
Does vitamin D make the world go 'round'? Mol Aspects Med. 2008 Dec;29(6):369–75.
The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008 Dec;29(6):369–75.
Gestational vitamin D deficiency: long-term effects on the brain. Nutr Rev. 2008 Dec;66(12):726–9.
Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review. Am J Clin Nutr. 2008 Dec;88(6):1528–34.
Vitamin D and diabetes: let the sunshine in. Diabetes Educ. 2008 Nov–Dec;34(6):939–40, 942, 944 passim.
The significance of Gc-globulin in clinical practice. Postepy Hig Med Dosw (Online). 2008 Nov 7;62:625–31.
Vitamin D deficiency during pregnancy and lactation. Ginekol Pol. 2008 Nov;79(11):780–4.
Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):752–7.
Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens. 2008 Nov;17(6):566–72.
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol—an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Dan Med Bull. 2008 Nov;55(4):186–210.
Prevention of falls. Clin Calcium. 2008 Nov;18(11):1600–9.
Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med. 2008 Nov;14(6):574–81.
PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics. 2008 Nov;9(11):1695–709.
Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol. 2008 Nov;117(11):864–70.
Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem. 2008 Nov;19(11):717–26.
Adequate level of vitamin D is essential for maintaining good health. Postepy Hig Med Dosw (Online). 2008 Oct 9;62:502–10.
Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006086.
Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008 Oct;66(10 Suppl 2):S98–112.
Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct;9(10):993–1001.
Sarcopenia in nursing home residents. J Am Med Dir Assoc. 2008 Oct;9(8):545–51.
Vitamin D: a rapid review. Urol Nurs. 2008 Oct;28(5):343–9, 384; quiz 350.
Vitamin D, aging, and cancer. Nutr Rev. 2008 Oct;66(10 Suppl 2):S147–52.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76.
Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis. Nat Clin Pract Rheumatol. 2008 Oct;4(10):550–6.
UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res. 2008 Oct;21(5):509–16.
Topical treatments in psoriasis: today and tomorrow. Clin Dermatol. 2008 Sep–Oct;26(5):432–7.
Vitamin D and mood disorders among women: an integrative review. J Midwifery Womens Health. 2008 Sep–Oct;53(5):440–6.
The "sunshine deficit" and cardiovascular disease. Circulation. 2008 Sep 30;118(14):1476–85.
Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008 Sep;76(9):3837–43.
The complex role of vitamin D in autoimmune diseases. Scand J Immunol. 2008 Sep;68(3):261–9.
The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):651–60.
Pediatric vitamin D and calcium nutrition in developing countries. Rev Endocr Metab Disord. 2008 Sep;9(3):181–92.
Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy. Curr Drug Saf. 2008 Sep;3(3):168–72.
Skeletal effects of systemic and topical corticosteroids. Curr Drug Saf. 2008 Sep;3(3):190–3.
Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008 Sep;8(9):685–98.
Evaluation and correction of low vitamin D status. Curr Osteoporos Rep. 2008 Sep;6(3):95–9.
Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):587–99.
New insights and therapies for teenage psoriasis. Curr Opin Pediatr. 2008 Aug;20(4):419–24.
The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol. 2008 Aug;17(8):633–9.
Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008 Aug;4(8):404–12.
Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr. 2008 Aug;88(2):520S–528S.
Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol. 2008 Aug;20(4):371–6.
Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008 Aug;88(2):558S–564S.
African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008 Aug;88(2):545S–550S.
Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008 Aug;88(2):500S–506S.
25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr. 2008 Aug;88(2):529S–533S.
Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr. 2008 Aug;88(2):513S–519S.
From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008 Aug;88(2):491S–499S.
Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008 Aug;122(2):398–417.
Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil. 2008 Jul–Aug;10(4):315–23.
Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5.
Calcium metabolism and anti-aging of bone. Clin Calcium. 2008 Jul;18(7):918–22.
The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):408–15.
L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol. 2008 Jul;16(7):336–44.
Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):348–52.
Vitamin D and prostate cancer risk—a less sunny outlook? J Natl Cancer Inst. 2008 Jun 4;100(11):759–61.
Epidemiologic risks for food allergy. J Allergy Clin Immunol. 2008 Jun;121(6):1331–6.
Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J. 2008 Jun;31(6):1322–33.
Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008 Jun;67(2–3):164–78.
Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med. 2008 Jun;162(6):513–9.
Dietary manipulation in musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2008 Jun;22(3):535–61.
Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 2008 Jun;34(3):193–205.
Osteoporosis in men. Endocr Rev. 2008 Jun;29(4):441–64.
Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. 2008 Jun;73(12):1355–63.
Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am. 2008 Jun;35(2):301–15, ix.
Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008 Jun;28 Suppl 3:S183–7.
Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord. 2008 Jun;9(2):145–51.
Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord. 2008 Jun;9(2):131–7.
The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys. 2008 May 15;473(2):225–30.
Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch Biochem Biophys. 2008 May 15;473(2):218–24.
The vitamin D receptor in cancer. Proc Nutr Soc. 2008 May;67(2):115–27.
Valid treatment options for osteoporosis and osteopenia in HIV-infected persons. Ann Pharmacother. 2008 May;42(5):670–9.
Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008 May;12(5):335–46.
Vitamin D and innate immunity. Curr Opin Investig Drugs. 2008 May;9(5):485–90.
Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84.
Review of the dietary reference intake for calcium: where do we go from here? Crit Rev Food Sci Nutr. 2008 May;48(5):378–84.
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin. 2008 May;24(5):1363–70.
Osteoporosis and its implications for dental patients. J Am Dent Assoc. 2008 May;139(5):545–52; quiz 625–6.
New approaches to treatment of secondary hyperparathyroidism. Curr Opin Investig Drugs. 2008 Apr;9(4):363–70.
Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med. 2008 Apr;46(4):298–302.
Celiac disease and the endocrinologist: a diagnostic opportunity. Endocr Pract. 2008 Apr;14(3):381–8.
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008 Apr;22(4):982–1001.
Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 Apr;87(4):1080S–6S.
Should we be concerned about the vitamin D status of athletes? Int J Sport Nutr Exerc Metab. 2008 Apr;18(2):204–24.
Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy. Nephrol Nurs J. 2008 Mar–Apr;35(2 Suppl):5S–22S; quiz 23S.
Hypothesis—ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol. 2008 Mar–Apr;84(2):356–65.
Can early onset bone loss be effectively managed in post-stroke patients? An integrative review of the evidence. Age Ageing. 2008 Mar;37(2):142–50.
The controversial role of vitamin D in the skin: immunosuppression vs. photoprotection. Clin Exp Dermatol. 2008 Mar;33(2):167–70.
Use of vitamin D in clinical practice. Altern Med Rev. 2008 Mar;13(1):6–20.
Nutritional bone disease in Indian population. Indian J Med Res. 2008 Mar;127(3):219–28.
Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure. 2008 Mar;17(2):181–6.
Human genes in TB infection: their role in immune response. Monaldi Arch Chest Dis. 2008 Mar;69(1):24–31.
Childhood asthma is a fat-soluble vitamin deficiency disease. Clin Exp Allergy. 2008 Mar;38(3):385–7.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38.
On the epidemiology of influenza. Virol J. 2008 Feb 25;5:29.
Sunlight, the vitamin D endocrine system, and their relationships with gynaecologic cancer. Maturitas. 2008 Feb 20;59(2):101–13.
Vitamin D status and bone biomarkers in childhood cancer. Pediatr Blood Cancer. 2008 Feb;50(2 Suppl):479–82; discussion 486.
Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfus Apher Sci. 2008 Feb;38(1):33–40.
Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008 Feb;37(1):113–9.
A 2008 panorama on osteoporosis and inflammatory bowel disease. Minerva Med. 2008 Feb;99(1):65–71.
A review of complementary and alternative approaches to immunomodulation. Nutr Clin Pract. 2008 Feb;23(1):49–62.
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):80–90.
Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol. 2008 Feb;194(1–2):7–17.
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008 Jan–Feb;14(1):18–27.
Osteoporosis in celiac disease and in endocrine and reproductive disorders. World J Gastroenterol. 2008 Jan 28;14(4):498–505.
Bone and mineral guidelines for patients with chronic kidney disease: a call for revision. Clin J Am Soc Nephrol. 2008 Jan;3(1):179–83.
Battleground: chronic kidney disorders mineral and bone disease—calcium obsession, vitamin d, and binder confusion. Clin J Am Soc Nephrol. 2008 Jan;3(1):168–73.
Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):7–12.
Pathogenesis, diagnosis and treatment of osteoporosis in men. Pol Merkur Lekarski. 2008 Jan;24(139):76–80.
Nutritional considerations in institutionalized elders. Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):1–6.
Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008 Jan;24(1):139–49.
Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:31–42.
Solar ultraviolet irradiance and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:16–30.
Diagnostic procedures and rationale for specific therapies in chronic kidney disease-mineral and bone disorder. Contrib Nephrol. 2008;161:222–33.
Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol. 2008;23(9):609–14.
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Intern Med. 2008;47(11):989–94.
Growth and bone development. Nestle Nutr Workshop Ser Pediatr Program. 2008;61:53–68.
Treatment of postmenopausal osteoporosis in women: a systematic review. Cad Saude Publica. 2008;24 Suppl 4:s592–606.
Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview. Cancer Detect Prev. 2008;32(1):52–64.
Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev. 2008;34 Suppl 1:S3–18.
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies. Cancer Treat Rev. 2008;34 Suppl 1:S31–42.
Aromatase inhibitor-associated bone loss: clinical considerations. Drugs. 2008;68(18):2591–600.
Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008;40(2):419–26.
Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol. 2008;83:305–28.
Pathophysiology and therapy of benign prostatic hyperplasia. Wien Klin Wochenschr. 2008;120(13–14):390–401.
Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203–14.
Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol. 2008;624:1–15.
Therapeutic potential of vitamin D for multiple sclerosis. Curr Med Chem. 2008;15(5):499–505.
Review: vitamin D, immunity and lupus. Lupus. 2008;17(1):6–10.
Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol. 2007 Dec 14;13(46):6156–65.
Importance of monotherapy in women across the reproductive cycle. Neurology. 2007 Dec 11;69(24 Suppl 3):S10–6.
Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease. Clin Calcium. 2007 Dec;17(12):1870–8.
CKD-MBD: impact on management of kidney disease. Clin Exp Nephrol. 2007 Dec;11(4):261–8.
Vitamin D, cardiovascular disease, and survival in dialysis patients. J Bone Miner Res. 2007 Dec;22 Suppl 2:V95–9.
Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res. 2007 Dec;22 Suppl 2:V91–4.
Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res. 2007 Dec;22 Suppl 2:V81–5.
Cancer treatment-induced bone loss. Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):442–5.
Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res. 2007 Dec;22 Suppl 2:V86–90.
The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res. 2007 Dec;33(10):537–42.
Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol. 2007 Dec;14(4):196–200.
Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res. 2007 Dec;22 Suppl 2:V20–4.
Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007 Dec;22 Suppl 2:V100–4.
Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50–4.
Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res. 2007 Dec;22 Suppl 2:V69–73.
Treatment and prevention of fractures in stroke patients. Nippon Rinsho. 2007 Nov 28;65 Suppl 9:555–8.
Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2193–203.
Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost. 2007 Nov;33(8):798–809.
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol. 2007 Nov;18(11):2810–6.
Vitamin D in defense of the human immune response. Ann N Y Acad Sci. 2007 Nov;1117:94–105.
Vitamin D: molecular mechanism of action. Ann N Y Acad Sci. 2007 Nov;1116:340–8.
Vitamin D and cancer. J Cancer Res Ther. 2007 Oct–Dec;3(4):225–30.
Vitamin D insufficiency—possible etiologic factor of autoimmune diseases. Ugeskr Laeger. 2007 Oct 22;169(43):3655–60.
Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas. 2007 Oct 20;58(2):117–37.
Interventions for the prevention of nutritional rickets in term born children. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006164.
Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Nephrology (Carlton). 2007 Oct;12(5):500–9.
Prospective studies of dietary vitamin D and breast cancer: more questions raised than answered. Nutr Rev. 2007 Oct;65(10):459–66.
LUTS treatment: future treatment options. Neurourol Urodyn. 2007 Oct;26(6 Suppl):934–47.
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730–7.
Assessment of endocrine and nutritional status in age-related catabolic states of muscle and bone. Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):604–10.
Diet and breast cancer risk reduction. J Natl Compr Canc Netw. 2007 Sep;5(8):711–718.
Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007 Sep;66(9):1137–42.
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem. 2007 Aug 1;15(15):5047–60.
Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest. 2007 Aug;37(8):607–22.
Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models. Nutr Rev. 2007 Aug;65(8 Pt 2):S131–3.
Vitamin D receptor gene (VDR) associations with cancer. Nutr Rev. 2007 Aug;65(8 Pt 2):S102–4.
Epidemiological studies of vitamin D and breast cancer. Nutr Rev. 2007 Aug;65(8 Pt 2):S80–3.
Vitamin D and the regulation of Wnt/beta-catenin signaling and innate immunity in colorectal cancer. Nutr Rev. 2007 Aug;65(8 Pt 2):S118–20.
Early life events in asthma—diet. Pediatr Pulmonol. 2007 Aug;42(8):663–73.
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1–235.
Vitamin D and autoimmune disease. Acta Med Indones. 2007 Jul–Sep;39(3):133–41.
Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial. 2007 Jul–Aug;20(4):309–15.
Mineral-bone disorder with chronic kidney disease. Vnitr Lek. 2007 Jul–Aug;53(7–8):841–51.
Preventing hip fracture after stroke. Top Stroke Rehabil. 2007 Jul–Aug;14(4):67–79.
Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment. Dtsch Med Wochenschr. 2007 Jul 29;132(27):1475–9.
Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266–81.
Vascular calcification in dialysis patients. Prilozi. 2007 Jul;28(1):215–24.
Diet and breast cancer: a review of the prospective observational studies. Cancer. 2007 Jun 15;109(12 Suppl):2712–49.
Rehabilitation of elderly patients after fracture. Rev Med Suisse. 2007 Jun 13;3(115):1512–4.
New perspectives in the management of secondary hyperparathyroidism. Mini Rev Med Chem. 2007 Jun;7(6):591–8.
Treatment of premature menopause in breast cancer patients. Acta Chir Belg. 2007 Jun;107(3):263–6.
Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. Altern Med Rev. 2007 Jun;12(2):113–45.
Vitamin d and its role in cancer and immunity: a prescription for sunlight. Nutr Clin Pract. 2007 Jun;22(3):305–22.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304.
The Role of Vitamin D and Calcium in type 2 diabetes. A systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2007 Jun;92(6):2017–29.
Molecular epidemiology of prostate cancer: hormone-related genetic loci. Front Biosci. 2007 May 1;12:3436–60.
New Active vitamin D analogs and calcimimetics to control hyperparathyroidism in chronic renal failure. Clin Calcium. 2007 May;17(5):767–71.
Effects of vitamin D on non-classical target organs and survival. Clin Calcium. 2007 May;17(5):691–7.
Hypercalcemia in sarcoidosis—case report, prevalence, pathophysiology and therapeutic options. Ther Umsch. 2007 May;64(5):281–6.
Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf. 2007 May;6(3):267–78.
Nutritional management of cystic fibrosis patients. Curr Opin Clin Nutr Metab Care. 2007 May;10(3):348–54.
Hiding from the sun—vitamin D deficiency in refugees. Aust Fam Physician. 2007 May;36(5):355–7.
Genetic factors associated with skin cancer in renal transplant patients. Photodermatol Photoimmunol Photomed. 2007 Apr–Jun;23(2–3):62–7.
The Epidemiology of Autism Spectrum Disorders. Annu Rev Public Health. 2007 Apr 21;28:235–258.
Interventions for the treatment of decreased bone mineral density associated with HIV infection. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005645.
Vitamin D and breast cancer. Ugeskr Laeger. 2007 Apr 2;169(14):1299–302.
The potential for vitamin D receptor activation in cardiovascular research. Expert Opin Investig Drugs. 2007 Apr;16(4):407–11.
The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM. 2007 Apr;100(4):185–92.
The influence of vitamin D deficiency on cancers and autoimmune diseases development. Endokrynol Pol. 2007 Mar–Apr;58(2):140–52.
Vascular calcification in chronic kidney failure: role of vitamin D receptor. Curr Opin Investig Drugs. 2007 Mar;8(3):237–47.
Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):487–90.
Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int. 2007 Mar;18(3):251–9.
Key issues in the diagnosis and management of tuberculosis. J R Soc Med. 2007 Mar;100(3):134–41.
Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):793–8.
Therapeutic implications of the TLR and VDR partnership. Trends Mol Med. 2007 Mar;13(3):117–24.
Natural approaches to epilepsy. Altern Med Rev. 2007 Mar;12(1):9–24.
Nuclear hormone receptors in human skin. Horm Metab Res. 2007 Feb;39(2):96–105.
Anti-epileptic medication and bone health. Osteoporos Int. 2007 Feb;18(2):129–42.
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):134–44.
Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6.
Falls—where do we stand? Mo Med. 2007 Jan–Feb;104(1):63–7.
Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22.
Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis. 2007 Jan;14(1):27–36.
Mechanisms of vascular calcification. Adv Chronic Kidney Dis. 2007 Jan;14(1):54–66.
Vitamin D in patients with kidney disease: cautiously optimistic. Adv Chronic Kidney Dis. 2007 Jan;14(1):22–6.
Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007 Jan;14(1):3–12.
Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):6–11.
Risk assessment for vitamin D. American Journal of Clinical Nutrition, Vol. 85, No. 1, 6–18, January 2007.
An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results Cancer Res. 2007;174:225–34.
The influence of isoflavonoids on the antitumor activity of vitamin D3. Postepy Hig Med Dosw (Online). 2007;61:253–60.
Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301–23.
Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease. Drugs. 2007;67(14):1999–2012.
Ectopic granule cells of the rat dentate gyrus. Dev Neurosci. 2007;29(1–2):14–27.
Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017–29.
Vitamin D—an emerging issue in skin cancer control. Implications for public health practice based on the Australian experience. Recent Results Cancer Res. 2007;174:197–204.
Vitamin D deficiency (in adults). Main symptoms: bone pain. Praxis (Bern 1994). 2006 Dec 13;95(50):1953–9; quiz 1960.
Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets. 2006 Dec;6(8):711–27.
Epidemic influenza and vitamin D. Epidemiol Infect. 2006 Dec;134(6):1129–40.
Immobilization and hip fracture. Clin Calcium. 2006 Dec;16(12):1991–98.
Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006 Dec;12(12):1162–74.
Sarcoidosis: the nephrologist's perspective. Am J Kidney Dis. 2006 Nov;48(5):856–70.
Body weight in patients with Parkinson's disease. Mov Disord. 2006 Nov;21(11):1824–30.
Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006 Nov;91(11):4223–31.
Rickets in the 17th century. J Bone Miner Res. 2006 Oct;21(10):1506–10.
Gene polymorphisms leading to calcified and stenotic aortic valves. Herz. 2006 Oct;31(7):635–43.
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006 Oct;372(1–2):33–42.
Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol. 2006 Sep–Oct;19(5):566–77.
Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006 Sep–Oct;10(5):377–85.
Endocrine diseases presenting with hypo- or hypercalcemia. Nippon Rinsho. 2006 Sep 28;Suppl 3:536–41.
Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust. 2006 Sep 4;185(5):268–272.
The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog Biophys Mol Biol. 2006 Sep;92(1):108–18.
The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int. 2006 Sep;79(3):129–37.
The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep. 2006 Sep;4(3):96–102.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79.
Does sunlight prevent cancer? A systematic review. Eur J Cancer. 2006 Sep;42(14):2222–32.
Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation? Prog Biophys Mol Biol. 2006 Sep;92(1):140–9.
The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol. 2006 Sep;92(1):9–16.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8.
Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006 Sep;92(1):60–4.
What is the optimal vitamin D status for health? Prog Biophys Mol Biol. 2006 Sep;92(1):26–32.
Vitamin D in foods and as supplements. Prog Biophys Mol Biol. 2006 Sep;92(1):33–8.
Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006 Sep;92(1):49–59.
Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep;92(1):39–48.
Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol. 2006 Sep;92(1):132–9.
Risks and benefits of sun exposure: implications for public health practice based on the Australian experience. Prog Biophys Mol Biol. 2006 Sep;92(1):173–8.
Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol. 2006 Sep;92(1):17–25.
Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest. 2006 Aug;36 Suppl 2:51–62.
Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis. 2006 Aug;12(8):797–813.
Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006 Aug;116(8):2062–72.
The antitumor efficacy of calcitriol: preclinical studies. Anticancer Res. 2006 Jul–Aug;26(4A):2543–9.
Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol). J Endocrinol Invest. 2006 Jul–Aug;29(7):665–74.
UV radiation and cancer prevention: what is the evidence? Anticancer Res. 2006 Jul–Aug;26(4A):2723–7.
Vitamin D and cancer. Anticancer Res. 2006 Jul–Aug;26(4A):2515–24.
Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res. 2006 Jul–Aug;26(4A):2581–8.
Vitamin D metabolism and chronic kidney disease. Clin Calcium. 2006 Jul;16(7):1143–46.
Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations. Growth Horm IGF Res. 2006 Jul;16 Suppl A:S79–83.
Recent studies on vitamin D metabolizing enzymes. Clin Calcium. 2006 Jul;16(7):1129–35.
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006 Jul;84(1):18–28.
Osteoporosis in men. J Am Acad Orthop Surg. 2006 Jun;14(6):347–53.
Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management. Curr Mol Med. 2006 Jun;6(4):395–400.
The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006 Jun;40(6):1158–61.
Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm. 2006 May–Jun;3(3):231–51.
Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol Pharm. 2006 May–Jun;3(3):212–22.
Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab. 2006 May;7(4):349–65.
Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006 May;81(5):662–72.
Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl. 2006 May;(243):59–64.
A potential role for vitamin D on HIV infection? Nutr Rev. 2006 May;64(5 Pt 1):226–33.
Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets. 2006 May;6(3):229–44.
Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int. 2006 May;78(5):257–70.
The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther. 2006 Apr;110(1):117–34.
Reproduction, endocrine disorders and celiac disease: risk factors of osteoporosis. Minerva Med. 2006 Apr;97(2):191–203.
Drug-induced renal calculi. Ann Urol (Paris). 2006 Apr;40(2):57–68.
Nutritional and metabolic complications of bariatric surgery. Am J Med Sci. 2006 Apr;331(4):219–25.
Preventing osteoporosis-related fractures: an overview. Am J Med. 2006 Apr;119(4 Suppl 1):S3–S11.
Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. Rev Gastroenterol Disord. 2006 Spring;6(2):63–71.
Chemoprevention in gastrointestinal cancers: current status. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):281–7.
Cardiovascular disease in chronic kidney failure: the role of VDR activators. Curr Opin Investig Drugs. 2006 Mar;7(3):206–13.
Calcific arteriolopathy (Calciphylaxis). Rev Med Interne. 2006 Mar;27(3):184–95.
High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006 Mar;81(3):353–73.
Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006 Mar 27;248(1–2):149–59.
Vitamin D and autoimmune disease—implications for practice from the multiple sclerosis literature. J Am Diet Assoc. 2006 Mar;106(3):418–24.
Vitamins. Pediatr Rev. 2006 Feb;27(2):44–55.
An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin. 2006 Feb;22(2):405–15.
Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006 Feb;5(2):114–7.
Nutraceuticals: do they work and when should we use them? Best Pract Res Clin Rheumatol. 2006 Feb;20(1):99–115.
The role of vitamin D in cancer prevention. Am J Public Health. 2006 Feb;96(2):252–61.
Genetic markers in the pathogenesis of osteopenia and osteoporosis in cystic fibrosis. Med Wieku Rozwoj. 2006 Jan–Mar;10(1 Pt 2):275–87.
Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact. 2006 Jan–Mar;6(1):27–35.
Cutaneous melanoma and intervention strategies to reduce tumor-related mortality: what we know, what we don't know, and what we think we know that isn't so. Dermatol Ther. 2006 Jan–Feb;19(1):50–69.
Osteoporosis and digestive disease. Rev Med Suisse. 2006 Jan 18;2(49):205–9.
Vitamin D analogs as anti-carcinogenic agents. Anticancer Agents Med Chem. 2006 Jan;6(1):53–71.
New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int. 2006 Jan;69(2):218–23.
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43.
Calcium, vitamin D and involutional osteoporosis. Curr Opin Clin Nutr Metab Care. 2006 Jan;9(1):13–7.
The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol. 2006 Jan;22(1):24–9.
Vitamin D and cardiovascular disease. Curr Med Chem. 2006;13(20):2443–7.
Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol. 2006;20(3):531–46.
Genetics of chronic obstructive pulmonary disease, beyond a1-antitrypsin deficiency. Curr Med Chem. 2006;13(24):2857–73.
Osteoporosis in men: prevalence and investigation. Clin Cornerstone. 2006;8 Suppl 3:S20–5.
Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006;8(5):279–302.
Epilepsy-related injuries. Epilepsia. 2006;47 Suppl 1:79–86.
High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clin Proc. 2006;81(3):353–373
Kidneys, hearts, hormones and immunomodulators: integrated understandings. Blood Purif. 2006;24(1):46–50.
The management of secondary osteoporosis. Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1021–37.
Hypercalciuria. Ann Endocrinol (Paris). 2005 Dec;66(6):532–9.
How to manage osteoporosis in children. Best Pract Res Clin Rheumatol. 2005 Dec;19(6):991–1005.
Ultraviolet Radiation, Vitamin D and Risk of Prostate Cancer and Other Diseases. Photochem Photobiol. 2005 Nov–Dec;81(6):1252–60.
Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 Nov;68(5):1973–81.
Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005 Oct;94(4):483–92.
Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 Oct;98(10):1024–7.
Calcium and vitamin D status in the adolescent: key roles for bone, body weight, glucose tolerance, and estrogen biosynthesis. J Pediatr Adolesc Gynecol. 2005 Oct;18(5):305–11.
Dietary recommendations to meet both endocrine and autocrine needs of Vitamin D. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):7–12.
The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):13–9.
Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):93–101.
Celiac disease in disguise. Rev Med Suisse. 2005 Sep 7;1(31):2008–11.
Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005 Sep;98(9):667–76.
Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab. 2005 Sep;31(4 Pt 1):318–25.
Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol Suppl. 2005 Sep;76:26–32.
Sun exposure and health. Nurs Stand. 2005 Aug 3–9;19(47):50–4.
C. elegans DAF-12, Nuclear Hormone Receptors and human longevity and disease at old age. Ageing Res Rev. 2005 Aug;4(3):351–71.
Regulation of sulfotransferases by xenobiotic receptors. Curr Drug Metab. 2005 Aug;6(4):299–307.
The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ. 2005 Aug;12 Suppl 1:991–8.
The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact. 2005 Jul–Sep;5(3):273–84.
Vitamin D treatment in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):315–21.
The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):307–14.
Vitamin D and the epidemiology of prostate cancer. Semin Dial. 2005 Jul–Aug;18(4):276–89.
Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75.
The role of vitamin D in protecting type 1 diabetes mellitus. Diabetes Metab Res Rev. 2005 Jul–Aug;21(4):338–46.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD000227.
Nutritional treatment of bone fracture. Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):377–81.
Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005 Jul;2(7):308–15.
The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl. 2005 Jun;(95):S37–42.
Impaired and repaired inhibitory circuits in the epileptic human hippocampus. Trends Neurosci. 2005 Jun;28(6):334–40.
Living in low-latitude regions in the United States does not prevent poor vitamin D status. Nutr Rev. 2005 Jun;63(6 Pt 1):203–9.
Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun;10(2):94–111.
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005 May 11;293(18):2257–64.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304.
Therapy insight: Osteoporosis in inflammatory bowel disease—advances and retreats. Nat Clin Pract Gastroenterol Hepatol. 2005 May;2(5):232–9.
Vitamins for epilepsy. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004304.
Dietary guidelines and implementation for celiac disease. Gastroenterology. 2005 Apr;128(4 Suppl 1):S121–7.
Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 Mar;62(3):265–81.
Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005;330:524–526 (5 March).
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005 Mar;16(2):83–95.
Considerations in the treatment of early osteoarthritis. Curr Rheumatol Rep. 2005 Mar;7(1):29–35.
Corticosteroid therapy. Praxis (Bern 1994). 2005 Feb 16;94(7):239–43.
There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase. J Endocrinol Invest. 2005 Feb;28(2):183–6.
Vitamin D intake: a global perspective of current status. J Nutr. 2005 Feb;135(2):310–6.
Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol. 2005 Feb;233(2):115–24.
An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. Urol Oncol. 2005 Jan–Feb;23(1):36–48.
An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part I. Urol Oncol. 2005 Jan–Feb;23(1):25–35.
Metabolism of vitamin D3 by cytochromes P450. Front Biosci. 2005 Jan 1;10:119–34.
Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease. Ital Heart J Suppl. 2005 Jan;6(1):25–8.
Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1. Methods Enzymol. 2005;400:165–91.
Male osteoporosis: new trends in diagnosis and therapy. Drugs Aging. 2005;22(9):741–8.
Identification of genetic risk factors for periodontitis and possible mechanisms of action. J Clin Periodontol. 2005;32 Suppl 6:159–79.
The role of vitamin D in the formation of granuloma and in calcium metabolism. Med Pregl. 2005;58 Suppl 1:17–20.
The role of vitamin D in the prevention of osteoporosis. Ann Med. 2005;37(4):278–85.
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1717S–20S.
Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004 Dec;229(11):1136–42.
Diagnosis and management of osteoporosis in inflammatory bowel disease. Minerva Med. 2004 Dec;95(6):481–7.
Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med. 2004 Dec;95(6):469–80.
Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1697S–705S.
Issues in establishing vitamin D recommendations for infants and children. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1759S–62S.
Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1710S–6S.
Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1763S–6S.
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S.
Osteoarthritis and osteoporosis in postmenopausal women: clinical similarities and differences. Menopause. 2004 Nov–Dec;11(6 Pt 1):615–21.
Treatment of bone disease in cystic fibrosis. Curr Opin Pulm Med. 2004 Nov;10(6):524–30.
The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2004 Nov;92(4):317–25.
Bone disorders associated with the human immunodeficiency virus: pathogenesis and management. Pharmacotherapy. 2004 Oct;24(10):1331–46.
Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:43–9.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56.
Vitamin D and survival of hemodialysis patients. Clin Calcium. 2004 Sep;14(9):64–8.
Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome. Semin Nephrol. 2004 Sep;24(5):423–5.
Hypovitaminosis D-induced pain. Nutr Rev. 2004 Sep;62(9):354–9.
Disturbances of calcium-PTH-vitamin D axis in chronic liver diseases. Arq Bras Endocrinol Metabol. 2004 Aug;48(4):443–50.
Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004 Aug;58(8):1095–109.
Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica. 2004 Jul;34(7):633–64.
Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. J Urol. 2004 Jul;172(1):12–9.
Bone disease in epilepsy. Curr Neurol Neurosci Rep. 2004 Jul;4(4):329–34.
Therapeutic potential of vitamin D-binding protein. Trends Biotechnol. 2004 Jul;22(7):340–5.
Nutrition for the pediatric office: update on vitamins, infant feeding and food allergies. Curr Opin Pediatr. 2004 Jun;16(3):314–20.
Sarcoidosis succumbs to antibiotics—implications for autoimmune disease. Autoimmun Rev. 2004 Jun;3(4):295–300.
Osteoporosis associated with inflammatory bowel diseases. Orv Hetil. 2004 May 16;145(20):1045–51.
Review article: Osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther. 2004 May 1;19(9):941–52.
1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):507–11.
Genetic markers in thyroid autoimmune diseases. Z Arztl Fortbild Qualitatssich. 2004 May;98 Suppl 5:13–5.
Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest. 2004 May;125(5):1859–76.
Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):611–4.
Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):575–9.
Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr. 2004 May;79(5):717–26.
Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):437–41.
Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004 Apr 28;291(16):1999–2006.
Extraintestinal manifestations of inflammatory bowel disease. Med Klin (Munich). 2004 Mar 15;99(3):123–30.
Systemic treatment of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2004 Mar;16(3):275–81.
Environmental causes: dietary causes. Endocrinol Metab Clin North Am. 2004 Mar;33(1):17–26, vii.
Metabolic bone disease in inflammatory bowel disease. J Clin Gastroenterol. 2004 Mar;38(3):218–24.
1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action. Endocr Regul. 2004 Mar;38(1):29–38.
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362–71.
Recommendations for the care of women with epilepsy. Cleve Clin J Med. 2004 Feb;71 Suppl 2:S49–57.
Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav. 2004 Feb;5 Suppl 2:S36–40.
Epilepsy and bone health in adults. Epilepsy Behav. 2004 Feb;5 Suppl 2:S24–9.
Climate change, ozone depletion and the impact on ultraviolet exposure of human skin. Phys Med Biol. 2004 Jan 7;49(1):R1–11.
Vitamin D receptor and analogs. Semin Nephrol. 2004 Jan;24(1):10–6.
Vitamin D and skin: new aspects for dermatology. Exp Dermatol. 2004;13 Suppl 4:11–5.
Prevention of hip fractures: medical and nonmedical management. Instr Course Lect. 2004;53:417–25.
Present position of the hormonal replacement therapy. Cas Lek Cesk. 2004;143(7):447–52.
Calcium and bone mineral metabolism in children with chronic illnesses. Annu Rev Nutr. 2004;24:13–32.
Management of osteoporosis in adults with cystic fibrosis. Drugs. 2004;64(2):133–47.
A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer. 2004;48(2):115–23.
Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence Experimental Biology and Medicine 229:1136–1142 (2004).
Nutritional management of multiple pregnancies. Twin Res. 2003 Dec;6(6):514–9.
Review article: chemotherapy for pancreatic cancer. Aliment Pharmacol Ther. 2003 Dec;18(11–12):1049–69.
Genetics of susceptibility and resistance to tuberculosis. Internist (Berl). 2003 Nov;44(11):1385–93.
Vitamin D and bone health in early life. Proc Nutr Soc. 2003 Nov;62(4):823–8.
Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab. 2003 Nov;14(9):423–30.
Hypovitaminosis D in older adults. Gerontology. 2003 Sep–Oct;49(5):273–8.
Menopause and bone density issues for women with epilepsy. Neurology. 2003 Sep 1;61(6 Suppl 2):S16–22.
Mediterranean diet, micronutrients and prostate carcinoma: a rationale approach to primary prevention of prostate cancer. Arch Ital Urol Androl. 2003 Sep;75(3):166–78.
Clinical pharmacology of old age syndromes. Br J Clin Pharmacol. 2003 Sep;56(3):261–72.
Management of osteoporosis due to ovarian failure. Med Pediatr Oncol. 2003 Sep;41(3):222–7.
An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women. Expert Opin Pharmacother. 2003 Sep;4(9):1479–88.
Musculoskeletal manifestations in cystic fibrosis. Joint Bone Spine. 2003 Sep;70(5):327–35.
Effects of vitamin d supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc. 2003 Sep;51(9):1219–26.
Osteoporosis and cardiovascular disease—two sides of the same coin? Med Klin (Munich). 2003 Aug 15;98(8):437–46.
Management of osteoporosis in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol. 2003 Aug;15(8):869–76.
Endocrine and reproductive manifestations of sarcoidosis. QJM. 2003 Aug;96(8):553–61.
The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol. 2003 Aug;15(8):857–64.
Bone loss associated with gastrointestinal disease: prevalence and pathogenesis. Eur J Gastroenterol Hepatol. 2003 Aug;15(8):851–6.
The role of the intestine in bone homeostasis. Eur J Gastroenterol Hepatol. 2003 Aug;15(8):845–9.
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003 Aug;88(8):3482–6.
Ultraviolet radiation: sun exposure, tanning beds, and vitamin D levels. What you need to know and how to decrease the risk of skin cancer. J Am Osteopath Assoc. 2003 Aug;103(8):371–5.
HIV infection—a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):281–91.
New vitamin D analogs. Kidney Int Suppl. 2003 Jun;(85):S83–7.
Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003 May;89(5):552–72.
Vitamin D receptor as a drug discovery target. Mini Rev Med Chem. 2003 May;3(3):193–204.
Fat redistribution and bone abnormalities in HIV-infected patients. J Int Assoc Physicians AIDS Care (Chic Ill). 2003 Apr–Jun;2(2):59–65.
Osteoporosis in men. Am Fam Physician. 2003 Apr 1;67(7):1521–6.
The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors. Can J Gastroenterol. 2003 Apr;17(4):265–71.
Role of vascular factors in osteoporosis. J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):362–6.
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci. 2003 Apr;987:258–61.
Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial. 2003 Mar–Apr;16(2):140–7.
New insights into the mechanisms of vitamin D action. J Cell Biochem. 2003 Mar 1;88(4):695–705.
Health disparities: reframing the problem. Med Sci Monit. 2003 Mar;9(3):SR9–15.
Mechanisms by which nutritional disorders cause reduced bone mass in adults. J Womens Health (Larchmt). 2003 Mar;12(2):145–50.
The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277–300.
Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt). 2003 Mar;12(2):151–6.
Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev. 2003 Mar;61(3):107–13.
Calcium and vitamin D. Endocrinol Metab Clin North Am. 2003 Mar;32(1):181–94, vii–viii.
Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003 Feb 1;88(2):327–31.
Vitamin D and autoimmune diabetes. J Cell Biochem. 2003 Feb 1;88(2):216–22.
Vitamin D: A millenium perspective. J Cell Biochem. 2003 Feb 1;88(2):296–307.
Rationale for active vitamin D and analogs in the treatment of osteoporosis. J Cell Biochem. 2003 Feb 1;88(2):381–6.
Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003 Feb;17(3):307–20.
Feeding of infants based on age. Practice guidelines. Arch Pediatr. 2003 Jan;10(1):76–81.
Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). Int J Oncol. 2003 Jan;22(1):5–13.
Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun. 2003 Jan;4(1):4–11.
Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res. 2003;164:319–32.
Topical immunomodulators for treatment of eczema. Wien Med Wochenschr. 2003;153(23–24):522–5.
Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res. 2003;164:99–110.
Ecologic studies of solar UVB radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371–7.
Vitamin D analogs and breast cancer. Recent Results Cancer Res. 2003;164:333–48.
Vitamin D autocrine system and prostate cancer. Recent Results Cancer Res. 2003;164:223–37.
Review of the concept of vitamin D "sufficiency and insufficiency." Nefrologia. 2003;23 Suppl 2:73–7.
Evolution and function of vitamin D. Recent Results Cancer Res. 2003;164:3–28.
Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology. 2002 Dec 27;181–182:71–8.
Bone and celiac disease. Calcif Tissue Int. 2002 Dec;71(6):465–71.
Treatment of the extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2002 Dec;4(6):513–6.
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002 Nov 12;167(10 Suppl):S1–34.
Novel therapies for atopic eczema. Curr Opin Investig Drugs. 2002 Nov;3(11):1596–603.
Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo-therapy and radiotherapy. Curr Med Chem Anti-Canc Agents. 2002 Nov;2(6):683–90.
Hypercalcemia in sarcoidosis. Nippon Rinsho. 2002 Sep;60(9):1778–84.
Bronchoalveolar lavage in sarcoidosis. Nippon Rinsho. 2002 Sep;60(9):1766–71.
Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol. 2002 Sep;17(9):938–48.
Few smokers develop COPD. Why? Respir Med. 2002 Aug;96(8):615–24.
Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002 Aug;147(2):197–213.
Perinatal events, vitamin D, and the development of allergy. Pediatr Res. 2002 Jul;52(1):3–5.
The role of vitamin D in mild to moderate chronic kidney disease. Trends Endocrinol Metab. 2002 Jul;13(5):189–94.
HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun;19(2):83–95.
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol. 2002 Jun;2(7):1017–28.
Can vitamin D supplementation in infancy prevent type 1 diabetes? Nutr Rev. 2002 Apr;60(4):118–21.
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002 Apr;8(4):174–9.
Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 2002 Apr;75(4):611–5.
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002 Apr;13(3):100–5.
Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am. 2002 Mar;31(1):107–19.
Vitamin D deficiency in UK Asian families: activating a new concern. Arch Dis Child. 2002 Mar;86(3):147–9.
Vitamin D and muscle function. Osteoporos Int. 2002 Mar;13(3):187–94.
Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002 Mar;9(1):45–59.
COPD and osteoporosis. Chest. 2002 Feb;121(2):609–20.
Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets. 2002 Feb;3(1):85–94.
Vitamin D and prostate cancer. J Androl. 2002 Jan–Feb;23(1):9–17.
Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly. 2002 Jan 26;132(3–4):27–37.
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Braz J Med Biol Res. 2002 Jan;35(1):1–9.
Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther. 2002 Jan;93(1):37–49.
Transcriptional regulation of the sodium-sulfate cotransporter NaS(i)-1 gene. Cell Biochem Biophys. 2002;36(2–3):175–82.
Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif. 2002;20(5):477–80.
Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism. Treat Endocrinol. 2002;1(5):313–27.
Vitamin D-related therapies in prostate cancer. Cancer Metastasis Rev. 2002;21(2):147–58.
Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant. 2002;17 Suppl 10:10–9.
Vitamin D analogs for the treatment of secondary hyperparathyroidism. Blood Purif. 2002;20(1):109–12.
The genetics of host resistance and susceptibility to tuberculosis. Ann N Y Acad Sci. 2001 Dec;953:151–6.
Vitamin D: its role and uses in immunology. FASEB J. 2001 Dec;15(14):2579–85.
Genetics of menopause-associated diseases. Maturitas. 2001 Nov 30;40(2):103–16.
Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci. 2001 Nov;22 Suppl 2:S117–22.
Vitamin D analogues for the management of secondary hyperparathyroidism. Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S34–40.
Micronutrients in women's health and immune function. Nutrition. 2001 Oct;17(10):858–67.
Full-spectrum fluorescent lighting: a review of its effects on physiology and health. Psychol Med. 2001 Aug;31(6):949–64.
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001 Aug;22(4):477–501.
How to prevent fractures in the individual with osteoporosis. Best Pract Res Clin Rheumatol. 2001 Jul;15(3):497–515.
Prevention of prostate cancer. Hematol Oncol Clin North Am. 2001 Jun;15(3):445–57.
Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Ann N Y Acad Sci. 2001 Jun;939:340–57.
Phosphate, the renal tubule, and the musculoskeletal system. Joint Bone Spine. 2001 May;68(3):211–5.
Vitamin D and genomic stability. Mutat Res. 2001 Apr 18;475(1–2):69–87.
Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol. 2001 Apr;137(4):477–81.
Vitamin D nutrition and bone disease in adults. Rev Endocr Metab Disord. 2001 Apr;2(2):153–64.
Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr. 2001 Apr;4(2B):547–59.
Role of estrogens in the management of postmenopausal bone loss. Rheum Dis Clin North Am. 2001 Feb;27(1):143–62.
Gonadal dysgenesis and bone metabolism. Joint Bone Spine. 2001 Feb;68(1):26–33.
The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum Dis Clin North Am. 2001 Feb;27(1):255–62.
An update on glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am. 2001 Feb;27(1):235–53.
Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med. 2001 Feb;7(2):201–9.
Bone and mineral metabolism in human immunodeficiency virus infection. J Bone Miner Res. 2001 Jan;16(1):2–9.
Vitamin D: balancing cutaneous and systemic considerations. South Med J. 2001 Jan;94(1):58–64.
Candidate foods in the Asia-Pacific region for cardiovascular protection: fish, fruit and vegetables. Asia Pac J Clin Nutr. 2001;10(2):134–7.
Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet. 2001;2:69–101.
Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). Biotechnol Annu Rev. 2001;7:179–94.
Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol. 2001;41:421–42.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2001;(1):CD000227.
Vitamin D deficiency among immigrants. Ugeskr Laeger. 2000 Nov 13;162(46):6196–9.
Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000 Nov;59(4):531–5.
Calcium and vitamin D. Diagnostics and therapeutics. Clin Lab Med. 2000 Sep;20(3):569–90.
Human 25-hydroxyvitamin D-1alpha-hydroxylase: cloning, mutations, and gene expression. Pediatr Nephrol. 2000 Jul;14(7):620–5.
Prostate cancer prevention trials in the USA. Eur J Cancer. 2000 Jun;36(10):1312–5.
Applying experiences from trials of bacille Calmette-Guérin vaccine. Clin Infect Dis. 2000 Jun;30 Suppl 3:S262–5.
Relationships among diet, physical activity and other lifestyle factors and debilitating diseases in the elderly. Eur J Clin Nutr. 2000 Jun;54 Suppl 3:S143–7.
Diet and nutrition in urologic cancer. W V Med J. 2000 May–Jun;96(3):449–54.
Bone mass and gastrointestinal disease. Ann N Y Acad Sci. 2000 May;904:564–70.
Human genetic susceptibility to tuberculosis. Ann Acad Med Singapore. 2000 May;29(3):298–304.
Respiratory medicine of cage and aviary birds. Vet Clin North Am Exot Anim Pract. 2000 May;3(2):423–52, vi.
Alternatives to hormone replacement therapy: raloxifene and tibolone. Z Arztl Fortbild Qualitatssich. 2000 Apr;94(3):205–9.
Influence of inhaled glucocorticoids on bone mineral density and bone metabolism. Rev Panam Salud Publica. 2000 Apr;7(4):211–8.
Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr. 2000 Apr;19(2):220–7.
Disorders of bone metabolism in gastrointestinal and hepatic diseases. Ned Tijdschr Geneeskd. 2000 Mar 4;144(10):462–7.
Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy. Environ Health Perspect. 2000 Mar;108 Suppl 1:71–8.
Advances in the development of retinoids as chemopreventive agents. J Nutr. 2000 Feb;130(2S Suppl):479S–482S.
Osteoporosis: a new challenge in cystic fibrosis. Pharmacotherapy. 2000 Jan;20(1):34–51.
Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr. 2000;10(2):151–8.
Vitamin D toxicity. Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):121–3.
A medical hypothesis: phosphorus balance and prostate cancer. Cancer Invest. 2000;18(7):664–9.
Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant. 2000;15 Suppl 5:18–24.
Glucocorticoid-induced osteoporosis: pathogenesis and management. J Bone Miner Metab. 2000;18(6):350–2.
Regulation of renal calbindin-D28K. Pharmacol Toxicol. 2000;87 Suppl 3:5–30.
1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59 Suppl 1:24–7.
Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence? Experimental Biology and Medicine 223:230–233 (2000).
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2000;(2):CD000227.
Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res. 1999 Dec 21;40(3):173–7.
How to succeed as a virus: strategies for dealing with the immune system. Vet Immunol Immunopathol. 1999 Dec 15;72(1–2):111–7.
Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy. Schweiz Med Wochenschr. 1999 Dec 11;129(49):1926–30.
The role of calcium in health and disease. Am J Obstet Gynecol. 1999 Dec;181(6):1560–9.
Drug-induced urinary calculi in 1999. Prog Urol. 1999 Dec;9(6):1023–33.
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest. 1999 Dec;116(6):1733–49.
Environmental factors in nonmelanoma and melanoma skin cancer. J Epidemiol. 1999 Dec;9(6 Suppl):S102–14.
Skin cancer and solar UV radiation. Eur J Cancer. 1999 Dec;35(14):2003–9.
Genetic mutation in the human 25-hydroxyvitamin D3 1alpha-hydroxylase gene causes vitamin D-dependent rickets type I. Mol Cell Endocrinol. 1999 Oct 25;156(1–2):7–12.
Current aspects of the pathogenesis and clinical characteristics of otosclerosis: possibilities of drug therapy. Orv Hetil. 1999 Oct 31;140(44):2435–40.
Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr. 1999 Oct;18(5 Suppl):392S–397S.
Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int. 1999 Oct;65(4):295–306.
Osteoporosis management. Int J Fertil Womens Med. 1999 Sep–Oct;44(5):241–9.
Epilepsy and pregnancy. Tidsskr Nor Laegeforen. 1999 Sep 30;119(23):3437–40.
Genetic risk factors for chronic obstructive pulmonary disease (COPD). Nippon Rinsho. 1999 Sep;57(9):1954–8.
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry. 1999 Sep;56(9):848–53.
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999 Aug;56(2):383–92.
Tuberculosis treatment for the beginning of the next century. Int J Tuberc Lung Dis. 1999 Aug;3(8):651–62.
'Like a thief in the night': the selectivity of degeneration in Parkinson's disease. Brain. 1999 Aug;122 ( Pt 8):1401–2.
Bones and Crohn's: problems and solutions. Inflamm Bowel Dis. 1999 Aug;5(3):212–27.
Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 1999 Aug;5(3):192–9.
Genetic causes of rickets. Curr Opin Pediatr. 1999 Aug;11(4):333–9.
Vitamin D analogs: perspectives for treatment. Miner Electrolyte Metab. 1999 Jul–Dec;25(4–6):337–41.
Phosphorus balance and prostate cancer. Indian J Exp Biol. 1999 Jul;37(7):623–6.
Chemoprevention of urological cancer. J Urol. 1999 Jun;161(6):1748–60.
Vitamin D and prostate cancer. Proc Soc Exp Biol Med. 1999 Jun;221(2):89–98.
The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase. Mol Cell Endocrinol. 1999 May 25;151(1–2):213–20.
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69(5):842–56.
Intervention studies on cancer. Eur J Cancer Prev. 1999 Apr;8(2):91–103.
In vivo function of VDR in gene expression-VDR knock-out mice. J Steroid Biochem Mol Biol. 1999 Apr–Jun;69(1–6):247–51.
Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol. 1999 Apr;94(4):878–83.
Disease caused by lack of sunlight: rickets and osteomalacia. Ned Tijdschr Geneeskd. 1999 Mar 20;143(12):593–7.
Seasonal variations in vitamin-D status and the incidence of tuberculosis in different countries. Respiration. 1999;66(2):196.
Studies of calcium in food supplements in humans. Ann N Y Acad Sci. 1999;889:128–37.
Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci. 1999;889:107–19.
Vitamin D and prostate cancer risk. Eur Urol. 1999;35(5–6):392–4.
Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control. 1998 Dec;9(6):567–82.
Bioactive phytochemicals with emphasis on dietary practices. Indian J Med Res. 1998 Nov;108:167–81.
Osteoporosis in women: prevention and treatment. J Am Pharm Assoc (Wash). 1998 Sep–Oct;38(5):614–23; quiz 623–4.
Osteoporosis in patients with cystic fibrosis. Clin Chest Med. 1998 Sep;19(3):555–67.
Progressive sensorineural hearing loss in cochlear otosclerosis. Acta Otorhinolaryngol Ital. 1998 Aug;18(4 Suppl 59):59–65.
A strategy for osteoporosis in gastroenterology. Eur J Gastroenterol Hepatol. 1998 Aug;10(8):689–96; discussion 696–8.
Growth, development and differentiation: a functional food science approach. Br J Nutr. 1998 Aug;80 Suppl 1:S5–45.
Nutritional modulation of host responses to mycobacteria. Front Biosci. 1998 Jul 20;3:e110–22.
The roles of calcium and vitamin D in the prevention of osteoporosis. Endocrinol Metab Clin North Am. 1998 Jun;27(2):389–98.
Estimation of the effect of increasing UVB exposure on the human immune system and related resistance to infectious diseases and tumours. J Photochem Photobiol B. 1998 Mar;42(3):167–79.
Mechanisms and functions of vitamin D. Nutr Rev. 1998 Feb;56(2 Pt 2):S4–10; discussion S 54–75.
Ultraviolet radiation as a risk factor on the Earth and outer space. Aviakosm Ekolog Med. 1998;32(1):4–13.
The immunogenetics of human infectious diseases. Annu Rev Immunol. 1998;16:593–617.
Host genetic susceptibility to human tuberculosis. Novartis Found Symp. 1998;217:3–13; discussion 13–23.
Season of birth in psychiatry. A review. Neuropsychobiology. 1998;37(4):175–81.
Biochemical changes in sarcoidosis. Clin Chest Med. 1997 Dec;18(4):827–42.
Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy? J Clin Pharmacol. 1997 Dec;37(12):1087–99.
Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol. 1997 Dec;32(12):1247–55.
Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res. 1997 Nov 7;28(1):1–38.
On the trail of genetic culprits in Williams syndrome. Cardiovasc Res. 1997 Nov;36(2):134–7.
Healthy aging. A women's issue. West J Med. 1997 Oct;167(4):220–32.
Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997 Oct;216(1):21–7.
The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997 Sep;154 Suppl:S57–73.
Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997 Aug;30(2 Pt 1):150–6.
Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. Int J Androl. 1997 Jun;20(3):134–43.
Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J. 1997 Jun;10(6):1380–91.
Osteomalacia. Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):145–63.
The brittle bone: how to save women from osteoporosis. Int J Fertil Womens Med. 1997 Mar–Apr;42(2):101–6.
Experimental evidence for cancer preventive elements in foods. Cancer Lett. 1997 Mar 19;114(1–2):11–7.
Bioavailability of vitamin D. Eur J Clin Nutr. 1997 Jan;51 Suppl 1:S76–9.
New rodent models for studies of chemopreventive agents. J Cell Biochem Suppl. 1997;28–29:144–7.
Nutrition and development: other micronutrients' effect on growth and cognition. Southeast Asian J Trop Med Public Health. 1997;28 Suppl 2:78–82. Review.
UV-induced cutaneous photobiology. Crit Rev Biochem Mol Biol. 1996 Dec;31(5–6):381–404.
Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci. 1996 Dec;312(6):278–86.
An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev. 1996 Nov;15(4):203–6.
Corticosteroid-induced bone loss. Prevention and management. Drug Saf. 1996 Nov;15(5):347–59.
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. CMAJ. 1996 Oct 1;155(7):955–61.
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. CMAJ. 1996 Oct 1;155(7):935–9.
Interactions between magnesium and vitamin D: possible implications in the immune system. Magnes Res. 1996 Oct;9(3):185–203.
Immunosuppression—a tightrope walk between iatrogenic harm and therapy. Schweiz Med Wochenschr. 1996 Sep 21;126(38):1603–9.
Pediatric diseases that affect bone metabolism. Rev Med Chil. 1996 Aug;124(8 Suppl):86–91.
Neurological complications of celiac disease: a rare but continuing problem. Am J Gastroenterol. 1996 Jul;91(7):1430–5.
Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochem J. 1996 Jun 1;316 ( Pt 2):361–71.
1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. J Investig Dermatol Symp Proc. 1996 Apr;1(1):68–71.
Vitamin D, calcium, and sarcoidosis. Chest. 1996 Feb;109(2):535–9.
Are there gender differences regarding coronary artery calcification. Am J Card Imaging. 1996 Jan;10(1):72–7.
Cellular biology of prostatic growth factors. Prostate Suppl. 1996;6:74–8.
Nutritional issues in nursing home care. Ann Intern Med. 1995 Dec 1;123(11):850–9.
The biomedical effects of ultraviolet radiation and their mechanisms. Usp Fiziol Nauk. 1995 Oct–Dec;26(4):98–112.
Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride. Ann N Y Acad Sci. 1995 Sep 15;765:236–47; discussion 248.
Sunlight—can it prevent as well as cause cancer? Cancer Res. 1995 Sep 15;55(18):4014–22.
Bone metabolism and osteopenia in eating disorders. Medicine (Baltimore). 1995 Sep;74(5):254–67.
New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995 Aug;17(2 Suppl):33S–38S.
Vitamin D deficiency in older people. J Am Geriatr Soc. 1995 Jul;43(7):822–8.
Genomic actions of 1,25-dihydroxyvitamin D3. J Nutr. 1995 Jun;125(6 Suppl):1690S–1694S.
Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol. 1995 May;7(3):249–54.
Polyglandular autoimmune syndrome. Nippon Rinsho. 1995 Apr;53(4):974–8.
Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S–645S.
Studies on health effects of cadmium exposure in the general environment. Nippon Eiseigaku Zasshi. 1995 Feb;49(6):960–72.
The vitamin D Endocrine system: manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppressive agents. J Cell Biochem Suppl. 1995;22:218–25.
Butyrate and phenylacetate as differentiating agents: practical problems and opportunities. J Cell Biochem Suppl. 1995;22:247–53.
The "vitamin D" endocrine and paracrine mediator in pulmonary granulomatosis. Rev Mal Respir. 1995;12(2):119–26.
Vitamin D and prostate cancer. Adv Exp Med Biol. 1995;375:53–63.
The prevalence of hypercalcaemia in pulmonary and miliary tuberculosis—a longitudinal study. Singapore Med J. 1994 Dec;35(6):613–5.
McCollum Award Lecture, 1994: vitamin D—new horizons for the 21st century. Am J Clin Nutr. 1994 Oct;60(4):619–30.
Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994 Jul;5(4):367–92.
Medulloblastoma. Semin Diagn Pathol. 1994 May;11(2):85–97.
Postmenopausal hormone replacement therapy—clinical implications. J Hypertens. 1994 Apr;12(4):429–37.
Metabolism and action of vitamin D in epileptic patients on anticonvulsive treatment and healthy adults. Dan Med Bull. 1994 Apr;41(2):139–50.
Vitamin D and the immune system. Pathol Biol (Paris). 1994 Feb;42(2):163–72.
Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol. 1994 Jan 1;139(1):16–29.
Myelofibrosis in severe combined immunodeficiency due to vitamin D deficiency rickets. Acta Haematol. 1994;92(3):160–3.
Metabolism of calcium in sarcoidosis. Postepy Hig Med Dosw. 1994;48(2):193–206.
Abnormal calcium and vitamin D metabolism in tuberculosis. Trop Geogr Med. 1994;46(5):280–2.
Glucocorticoid osteoporosis. J Asthma. 1994;31(1):7–18.
Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol. 1994;364:109–14.
Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol. 1993 Jun 15;137(12):1302–17.
Reoperation for suspected primary hyperparathyroidism. Br J Surg. 1993 Apr;80(4):453–6.
Hypervitaminosis D. Nippon Rinsho. 1993 Apr;51(4):984–8.
Vitamin therapy in cystic fibrosis—a review and rationale. J Clin Pharm Ther. 1993 Feb;18(1):33–8.
Towards preventive dietetics in children. Rev Prat. 1993 Jan 15;43(2):171–6.
Health effects of ultraviolet radiation. Ann Physiol Anthropol. 1993 Jan;12(1):1–10.
Beneficial effects of sun exposure on cancer mortality. Prev Med. 1993 Jan;22(1):132–40.
Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. Ann Epidemiol. 1993 Jan;3(1):103–10.
Magnesium and immune function: recent findings. Magnes Res. 1992 Dec;5(4):281–93.
Vitamin D prophylaxis in childhood. Minerva Pediatr. 1992 Nov;44(11):533–49.
HIV cofactors in the course of AIDS. Presse Med. 1992 Sep 19;21(30):1426–30.
Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992 May;49(1):26–31.
Role of ultraviolet radiation and vitamin D metabolism in medical care during space flights. Aviakosm Ekolog Med. 1992 Mar–Apr;26(2):4–6.
Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol. 1992 Mar;11(1):28–36.
Vitamin D and the immune system. J Endocrinol. 1992 Feb;132(2):173–5.
Preventing wintertime bone loss: effects of vitamin D supplementation in healthy postmenopausal women. Nutr Rev. 1992 Feb;50(2):52–4.
Endocrine complications of sarcoidosis. Endocrinol Metab Clin North Am. 1991 Sep;20(3):645–54.
Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S–201S.
Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):189–201.
Is there a role for vitamin D in osteoporosis? Calcif Tissue Int. 1991;49 Suppl:S46–9.
Urinary calculi in hypercalcemic states. Endocrinol Metab Clin North Am. 1990 Dec;19(4):839–49.
The mechanisms of vitamin D toxicity. Bone Miner. 1990 Dec;11(3):267–72.
Oral manifestations of metabolic bone disease: vitamin D and osteoporosis. Compendium. 1990 Oct;11(10):612, 614–8.
Mineral and vitamin D adequacy in infants fed human milk or formula between 6 and 12 months of age. J Pediatr. 1990 Aug;117(2 Pt 2):S134–42.
Evaluation and treatment of complications of thyroid and parathyroid surgery. Otolaryngol Clin North Am. 1990 Jun;23(3):529–52.
Calcium metabolism disorders in sarcoidosis. Ann Med Interne (Paris). 1990;141(6):531–4.
An emerging view of vitamin D. Scand J Clin Lab Invest Suppl. 1990;201:127–33.
Parvalbumin, molecular and functional aspects. Adv Exp Med Biol. 1990;269:57–66.
Aluminum toxicity. Klin Wochenschr. 1989 Dec 15;67(24):1221–8.
Vitamin D: can an upper limit be defined? J Nutr. 1989 Dec;119(12 Suppl):1825–8.
Pathogenesis of hypercalcemia and alterations in vitamin D metabolism in sarcoidosis and other granulomatous disorders. Harefuah. 1989 Nov 1;117(9):265–8.
Treatment of hypercalcemia. Endocrinol Metab Clin North Am. 1989 Sep;18(3):807–28.
Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am. 1989 Sep;18(3):765–78.
1,25-Dihydroxyvitamin D3 and the immune system. Proc Soc Exp Biol Med. 1989 Jul;191(3):238–45.
The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989 Apr 13;320(15):980–91.
Increasing rates of depression. JAMA. 1989 Apr 21;261(15):2229–35.
X-ray microanalysis of mammalian salivary glands. Scanning Microsc. 1989 Mar;3(1):225–39; discussion 239–41.
The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. J Acquir Immune Defic Syndr. 1989;2(3):235–47.
Anticonvulsant-induced osteomalacia (review of the literature). Zh Nevropatol Psikhiatr Im S S Korsakova. 1989;89(8):122–7.
Short stature in children with atopic eczema. Acta Derm Venereol Suppl (Stockh). 1989;144:41–4.
Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology (Berl). 1989;97(3):285–94.
Nutrition in the elderly. Ann Intern Med. 1988 Dec 1;109(11):890–904.
Prevention of rickets in premature infants and in children with various chronic disease. Pol Tyg Lek. 1988 Nov 28;43(48):1565–8.
Vitamin D as an immuno-hematopoietic hormone. New perspectives on a previously known substance. Schweiz Med Wochenschr. 1988 Oct 15;118(41):1463–7.
Photoimmunology: the mechanisms involved in immune modulation by UV radiation. J Photochem Photobiol B. 1988 Sep;2(2):149–77.
Osteopathia antiepileptica in adolescents and adults. Fortschr Neurol Psychiatr. 1988 Jul;56(7):216–30.
Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. Arch Dermatol. 1987 Dec;123(12):1677–1683a.
Vitamin D and the immune system. Steroids. 1987 Jan–Mar;49(1–3):55–72.
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24.
Immunological consequences of ultraviolet radiation exposure. Photodermatol. 1986 Oct;3(5):284–97.
Biological effect of human ultraviolet irradiation. Vopr Kurortol Fizioter Lech Fiz Kult. 1986 Sep–Oct;(5):66–70.
Pathogenesis and management of primary osteoporosis. Clin Pharm. 1986 Aug;5(8):639–59.
Hypocalcemia in childhood. Pediatriia. 1986 May;(5):71–5.
Glucocorticoids and macrophage functions. Rev Med Interne. 1986 Mar;7(2):153–61.
Prospects for using ultraviolet radiation in protracted space flights. Kosm Biol Aviakosm Med. 1986 Jan–Feb;20(1):4–12.
Aging and calcium. Miner Electrolyte Metab. 1986;12(3):149–56.
The metabolism and functions of vitamin D. Adv Exp Med Biol. 1986;196:361–75.
Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol. 1985 Dec;43(2–3):113–22.
Parathyroid tumors. Curr Probl Cancer. 1985 Nov;9(11):1–52.
Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3. Endocr Rev. 1985 Fall;6(4):491–511.
Vitamin D. II. Clinico-therapeutic implications. Med Clin (Barc). 1985 May 4;84(17):700–11.
Synthesis of Vitamin D in the skin. Postepy Hig Med Dosw. 1985 Jan–Feb;39(1):85–104.
Metabolic mechanisms of drug-nutrient interactions. Fed Proc. 1985 Jan;44(1 Pt 1):124–9.
The nutritional state and nutrition. Acta Paediatr Scand Suppl. 1985;317:31–7.
Vitamin D: metabolism and biological properties. Ann Med Interne (Paris). 1985;136(2):154–63.
Side effects of antiepileptic drugs. Neurol Neurochir Pol. 1984 Nov–Dec;18(6):575–81.
Myopathies in endocrine disorders. Monatsschr Kinderheilkd. 1984 Aug;132(8):581–6.
Hypercalcemia. Vet Clin North Am Small Anim Pract. 1984 Jul;14(4):891–910.
Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci. 1984 May–Jun;14(3):189–97.
Metabolism of 1,25-dihydroxyvitamin D3. Physiol Rev. 1984 Apr;64(2):478–504.
Pathophysiology of hyperparathyroidism. Horm Res. 1984;20(1):38–43.
Ethnicity and health: a research review. Soc Sci Med. 1984;19(7):663–70.
Vitamin D: metabolism and biological actions. Annu Rev Nutr. 1984;4:493–520.
Vitamin D: recent advances. Annu Rev Biochem. 1983;52:411–39.
Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982 Nov;36(5 Suppl):1014–31.
Controlled trials in epilepsy: a review. Epilepsia. 1982 Oct;23(5):491–519.
Rickets in children induced by anticonvulsant therapy. Pediatriia. 1982 Jun;(6):75–7.
Disorder of calcium metabolism in sarcoidosis. Nippon Rinsho. 1982;40(12):2702–7.
Mechanisms of hypercalciuria. Pathobiol Annu. 1982;12:185–201.
Endocrine aspects of nephrolithiasis. Spec Top Endocrinol Metab. 1982;3:57–86.
Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D. Endocr Rev. 1981 Summer;2(3):264–74.
Vitamin D: metamorphosis from nutrient to hormonal system. Proc Nutr Soc. 1981 May;40(2):179–86.
Vitamin D physiology and its application to disorders of calcium metabolism. Recenti Prog Med. 1981 Feb;70(2):119–40.
Biochemical and clinical aspects of vitamin D function. Br Med Bull. 1981 Jan;37(1):37–42.
Recent advances on vitamin D. Diabete Metab. 1980 Jun;6(2):159–68.
Hormonal aspects of vitamin D metabolism and its clinical implications. Clin Endocrinol Metab. 1979 Nov;8(3):547–77.
Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone. Klin Wochenschr. 1979 Oct 1;57(19):1053–9.
Cystic fibrosis and malnutrition. J Pediatr. 1979 Sep;95(3):337–47.
Intestinal calcium transport absorption, secretion, and vitamin D. Int Rev Physiol. 1979;19:227–61.
Vitamin D in chronic liver disease. Prog Liver Dis. 1979;6:539–55.
The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med. 1978 Oct;129(4):278–320.
Metabolic and immunological disorders induced by long-term treatment with phenytoin. Neurol Neurochir Pol. 1978 May–Jun;12(3):321–5.
Vitamin D and calcium transport. Ann N Y Acad Sci. 1978 Apr 28;307:356–76.
Enzyme induction by drugs. Its relevance to clinical biochemistry. Ann Clin Biochem. 1978 Jan;15(1):55–64.
Human prolactin: clinical implications. Clin Invest Med. 1978;1(1):5–6.
Interrelationships of mycotoxins with nutrition. Fed Proc. 1977 May;36(6):1899–902.
Vitamin D as a prohormone. Biochem Pharmacol. 1977 Apr 1;26(7):563–6.
Interactions with antiepileptic drugs. Drugs. 1977 Apr;13(4):266–75.
Hypo- and hyperparathyroidism in pregnancy. Z Gesamte Inn Med. 1977 Mar 1;32(5):113–8.
Interrelationships between the key elements of the vitamin D endocrine system: 25-OH-D3-1-hydroxylase, serum calcium and phosphorus levels, intestinal 1,25(OH)2D3, and intestinal calcium binding protein. Adv Exp Med Biol. 1977;81:211–31.
Regulation of vitamin D metabolism in the kidney. Adv Exp Med Biol. 1977;81:195–209.
Physiologic role, biosynthesis and use of 1,25-dihydroxyvitamin D3 (review). Prikl Biokhim Mikrobiol. 1976 Nov–Dec;12(6):805–18.
Critical remarks on the concept of "osteopathia antiepileptica." Psychiatr Neurol Med Psychol (Leipz). 1976 Sep;28(9):538–47.
Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41.
Recent advances in our understanding of the vitamin D endocrine system. J Lab Clin Med. 1976 Jan;87(1):7–26.
Enzyme-inducing agents and their effect on vitamin D metabolism. Front Gastrointest Res. 1976;2:32–70.
Advances in the knowledge of the metabolism of vitamin D. Proc Nutr Soc. 1975 Sep;34(2):139–43.
Epidemiological and dietary aspects of rickets and osteomalacia. Proc Nutr Soc. 1975 Sep;34(2):131–8.
Factors in human vitamin D nutrition and in the production and cure of classical rickets. Proc Nutr Soc. 1975 Sep;34(2):119–30.
Recent clinical correlates of vitamin D metabolites and calcium metabolism. Nutr Rev. 1975 Jul;33(7):209–10.
Rheumatology in 1971–72–73–74. Rev Prat. 1975 Jun 21;25(35):2717–51.
Vitamin D today. Dis Mon. 1975 Mar:1–37.
The kidney as an endocrine organ involved in the function of vitamin D. Am J Med. 1975 Jan;58(1):39–47.
Steroid hormone receptors. Vitam Horm. 1975;33:649–736.
Osteopathies, calcium- and vitamin D metabolism errors during anti-epileptic long term therapy. Bibl Psychiatr. 1975;(151):114–43.
Vitamin D: the vitamin and the hormone. Fed Proc. 1974 Nov;33(11):2211–9.
Calcium homeostasis and the patogenesis and management of hypercalcemic disorders. Metabolism. 1974 Oct;23(10):975–1007.
Fluoride therapy for osteoporotic lesions. Ann Otol Rhinol Laryngol. 1974 Sep–Oct;83(5):626–34.
Topical clinical problems of vitamin D research (author's transl). MMW Munch Med Wochenschr. 1974 Sep 13;116(37):1565–8.
Generalised disorders of bone associated with disease of the gastro-intestinal tract. Ir J Med Sci. 1974 Jul;0(0):suppl:57–63.
Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis. West J Med. 1974 Jul;121(1):22–44.
Differential diagnosis of hypercalcuria. Med Klin. 1974 Jun 28;69(26):1170–3.
Vitamin D hormones. 2. Med J Aust. 1974 Jun 1;1(22):891–6.
Malabsorption following gastrectomy and ileal resection. Surg Clin North Am. 1974 Jun;54(3):647–53.
Symposium on renal lithiasis. Medical evaluation of urolithiasis. Etiologic aspects and diagnostic evaluation. Urol Clin North Am. 1974 Jun;1(2):241–60.
Inter-relationships of nutrition and the metabolism of drugs. Chem Biol Interact. 1974 Mar;8(3):193–206.
Magnesium in the nutrition of the child. Clin Pediatr (Phila). 1974 Mar;13(3):263–7 passim.
Calcium absorption in health and disease. II. Syndromes of imparied calcium absorption (author's transl). Klin Wochenschr. 1974 Jan 15;52(2):64–73.
The metabolism of vitamin D; recent developments and their clinical relevance. Neth J Med. 1974;17(3):131–9.
Molecular action of vitamin D in the chick intestine. Vitam Horm. 1974;32:277–98.
The hormone-like action of 1,25-(OH)2-cholecalciferol (a metabolite of the fat-soluble vitamin D) in the intestine. Vitam Horm. 1974;32:325–84.
Synthetic analogs of 1alpha,25-dihydroxyvitamin D3 and their biological activity. Vitam Horm. 1974;32:385–406.
Editorial: Role of the kidney in the metabolism of calciferol (vitamin D). Clin Nephrol. 1973 Sep–Oct;1(5):273–83.
Active metabolites of vitamin D. Pol Tyg Lek. 1973 Sep 27;28(35):1372–4.
The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone. N Engl J Med. 1973 Aug 16;289(7):359–65.
Effects of antiepileptic drugs in pregnancy on the fetus and newborn infant. Ann Clin Res. 1973 Aug;5(4):205–7.
Vitamin D metabolism and chronic kidney insufficiency. Dtsch Med Wochenschr. 1973 Jul 6;98(27):1338–44.
So-called rickets-like diseases in children. Pediatriia. 1973 Jul;52(7):83–8.
Vitamin D: a reawakening. JAMA. 1973 Jun 11;224(11):1526–7.
Progress in endocrinology and metabolism. Vitamin D: current concepts. Metabolism. 1973 Mar;22(3):507–31.
Vitamin D metabolism. Recent advances. Arch Dis Child. 1973 Jan;48(1):2–7.
Preparation of diabetics for oral surgery. Wiad Lek. 1973 Nov 15;26(22):2097–101.
Disordered calcium metabolism during anticonvulsant treatment. Ger Med. 1973 Winter;3(3–4):140–4.
The influence of nutrition response to infectious disease. Adv Vet Sci Comp Med. 1973;17:265–89.
New data on the metabolism and mechanism of action of vitamin D. Vopr Med Khim. 1973;19(6):563–7.
Pathophysiology, diagnosis and treatment of osteomalacia. Orthop Clin North Am. 1972 Nov;3(3):623–52.
Editorial: Vitamin D, the kidney and calcium homeostasis. Kidney Int. 1972 Nov;2(5):241–6.
Hypophosphataemic osteomalacia in adults. Lancet. 1971 Jun 26;1(7713):1343.
Abnormal calcium metabolism in Basedow's disease. Nippon Rinsho. 1971 May;29(5):1340–6.
Vitamin D: new findings on its metabolism and its role in calcium nutrition. Proc Nutr Soc. 1971 May;30(1):47–58.
Osteomalacia and anticonvulsant drugs. Nutr Rev. 1971 Feb;29(2):38–41.
New data on monoamine oxidase inhibitors. Vestn Akad Med Nauk SSSR. 1971;26(11):23–8.
Malabsorption in cirrhosis. Am J Clin Nutr. 1970 Apr;23(4):488–92.
Role of hormones in magnesium metabolism. Sem Hop. 1969 Jun 8;45(27):1895–900.
Studies on the mode of action of vitamin D. Bibl Nutr Dieta. 1969;13:6–16.
Endocrine aspects of sarcoidosis. N Engl J Med. 1968 Feb 22;278(8):427–34.
Treatment of miscellaneous disorders of growth. Mod Treat. 1968 Jan;5(1):218–40.
Tetany of early infancy as an expression of a transitory, idiopathic hypoparathyroidism. Z Kinderheilkd. 1967;99(3):211–23.
Clinical and pathogenetic aspects of hypercalcemia. Dtsch Arch Klin Med. 1964 Jan 9;209:219–56.
On vitamin d therapy of non-hypovitaminosis diseases. Ther Ggw. 1963 Sep;102:980–94.
Bone and joint manifestations of Besnier-Boeck-Schaumann sarcoidosis. Fr Med. 1963 May;26:249–59.
Effect of X-irradiation on the response of animal cells to virus. Prog Med Virol. 1963;5:127–68.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.